HARRISBURG, Pa., Oct. 20, 2021 /PRNewswire/ -- Attorneys working with The Amistad Project presented arguments before the Commonwealth Court of Pennsylvania today contending that Acting Secretary of Health Alison Beam drastically exceeded her authority by issuing a statewide mask mandate for all schools without promulgating a regulation empowering her to do so.
Search / 1995 results found Showing: 1-10 of 1995
PHILADELPHIA and LONDON, Oct. 20, 2021 /PRNewswire/ -- GlaxoSmithKline plc today announced that the US Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) voted unanimously to recommend two doses of Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) and its complications in adults 19 years of age and older who are or will be immunodeficient or immunosuppressed due to disease or therapy.
ERIE, Pa., Oct. 20, 2021 /PRNewswire/ -- Penelec, a subsidiary of FirstEnergy Corp. (NYSE: FE), has placed markers on a long stretch of power line in the Erie National Wildlife Refuge in Crawford County, Pennsylvania, to help bald eagles avoid in-flight collisions that could cause power outages as they fly between their nest and fishing grounds.
HARRISBURG, Pa., Oct. 20, 2021 /PRNewswire/ -- Today, the Pennsylvania Conference of Teamsters announced they will be endorsing Josh Shapiro for Governor. Shapiro currently serves as the Pennsylvania Attorney General.
PITTSBURGH, Oct. 20, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) is proud to confirm that Express Scripts, a leading pharmacy benefit management organization, will list Viatris' interchangeable biosimilar Semglee® (insulin glargine-yfgn) injection as a preferred insulin brand on its National Preferred Formulary® (NPF), which includes more than 28 million lives. Broad coverage of Viatris' interchangeable biosimilar by Express Scripts will help ensure that the many patients in the Express Scripts network who need insulin may receive the full benefits of and access to treatment with lower or maintained out-of-pocket costs.
EXTON, Pa., Oct. 20, 2021 /PRNewswire/ -- Following the May 2020 European Medicines Agency (EMA) approval of Bristol Myers Squibb's Zeposia and the May 2021 approval of Janssen's Ponvory, there are now four S1P receptor modulators (including Novartis' Gilenya and Mayzent) available on the European multiple sclerosis (MS) market. The Medicines and Healthcare products Regulatory Agency (MHRA) approval of Ponvory in August 2021 created a similar competitive landscape in the United Kingdom (UK).
LEHIGH VALLEY, Pa., Oct. 20, 2021 /PRNewswire/ -- Air Products (NYSE:APD), the global leader in production of gas separation and purification membranes, today announced a new brand identity for its world-leading membrane business units, which will now all operate around the world as Air Products Membrane Solutions.
PHILADELPHIA, Oct. 20, 2021 /PRNewswire/ -- Audacy, Inc. (NYSE: AUD) today announced the acquisition of an exclusive, perpetual license to WideOrbit's digital audio streaming technology and the related assets and operations of WO Streaming. This acquisition gives Audacy control of its product roadmap to deliver enhanced consumer-facing streaming features for its 170 million monthly listeners.
PITTSBURGH, Oct. 20, 2021 /PRNewswire/ -- The PNC Foundation today announced a five-year, $16.8 million grant to create The Howard University and PNC National Center for Entrepreneurship – aimed at building resources and support for Black business owners across the country. The center will support expanded opportunities for Black entrepreneurship with enhanced educational, leadership and capacity-building resources and programs nationwide. All of this furthers PNC's overall commitment to increase access to financial services and capital in LMI-communities and to Black and minority entrepreneurs and their small businesses.